Clinical Features

Prostate cancer incidence and mortality in Europe: implications for screening activities

Prostate cancer is the most commonly diagnosed cancer in men and the third leading cause of cancer-related deaths among males in Europe.

Prostate cancer incidence and mortality in Europe: implications for screening activities

Prostate cancer in Europe: the statistics

Prostate cancer is the most commonly diagnosed cancer in men and the third leading cause of cancer-related deaths among males in Europe. In the European Economic Area, which includes the 26 member states of the European Union, Iceland, Liechtenstein, and Norway, with a population of 219 million men, approximately 341,000 were diagnosed with prostate cancer in 2020 (accounting for 23% of all male cancers). In the same year, around 71,000 men died from prostate cancer (representing 10% of all male cancer-related deaths). There is a significant gap between the number of new diagnoses and the number of deaths from this malignancy, which explains why about 4 million Europeans (equivalent to 1.7% of all men) are living after a prostate cancer diagnosis.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free